Cargando…

Macrophages’ M1 or M2 by tumor microparticles: lysosome makes decision

Detalles Bibliográficos
Autores principales:	Tang, Ke, Ma, Jingwei, Huang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508130/ https://www.ncbi.nlm.nih.gov/pubmed/35773394 http://dx.doi.org/10.1038/s41423-022-00892-z

Ejemplares similares

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

Chemo-drugs in cell microparticles reset antitumor activity of macrophages by activating lysosomal P450 and nuclear hnRNPA2B1
por: Wei, Keke, et al.
Publicado: (2023)

Macrophages reprogrammed by lung cancer microparticles promote tumor development via release of IL-1β
por: Chen, Jie, et al.
Publicado: (2019)

Cost-effectiveness thresholds or decision-making threshold: a novel perspective
por: Sun, Lihua, et al.
Publicado: (2023)

Exosomal miR-19b-3p communicates tubular epithelial cells and M1 macrophage
por: Wang, Zhi-wei, et al.
Publicado: (2019)

Prediction models for COVID-19 clinical decision making
por: Leeuwenberg, Artuur M, et al.
Publicado: (2020)

COVID-19 serosurveys for public health decision making
por: Murhekar, Manoj V, et al.
Publicado: (2021)

Comment on: The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ
por: Schymik, Hanna S., et al.
Publicado: (2022)

Reply to the Comment on “The m6A Reader IGF2BP2 Regulates Macrophage Phenotypic Activation and Inflammatory Diseases by Stabilizing TSC1 and PPARγ”
por: Wang, Xia, et al.
Publicado: (2022)

NDRG2 programs tumor-associated macrophages for tumor support
por: von Karstedt, Silvia
Publicado: (2018)

Extracellular protein degradation via the lysosome
por: Eldeeb, Mohamed A., et al.
Publicado: (2020)

The UK COVID-19 Inquiry must examine the foundations of pandemic decision making
por: Lawton, Tom, et al.
Publicado: (2022)

Defining collaborative surveillance to improve decision making for public health emergencies and beyond
por: Archer, Brett N, et al.
Publicado: (2023)

Glucocerebrosidase mutations disrupt the lysosome and now the mitochondria
por: Klein, Andrés D., et al.
Publicado: (2023)

Does determining the degree of frailty help pandemic decision-making when resources are scarce?
por: Searle, Samuel D, et al.
Publicado: (2021)

Informing clinical decision making during a pandemic — a call for better preparedness
por: Vart, Priya, et al.
Publicado: (2023)

Emerging links between m(6)A and misregulated mRNA methylation in cancer
por: Jaffrey, Samie R., et al.
Publicado: (2017)

IgM Promotes the Clearance of Small Particles and Apoptotic Microparticles by Macrophages
por: Litvack, Michael L., et al.
Publicado: (2011)

Actively or passively deacidified lysosomes push β-coronavirus egress
por: Wang, Xuefeng, et al.
Publicado: (2021)

Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
por: Chen, Degao, et al.
Publicado: (2018)

“Sorry ICU, I’m an Ophthalmologist!”
por: Yang, Elizabeth, et al.
Publicado: (2020)

ECI biocommentary: Jason M. Nagata
por: Nagata, Jason M.
Publicado: (2022)

4EBP1/2 are active under standard cell culture conditions to regulate the translation of specific mRNAs
por: Alasad, Khawla, et al.
Publicado: (2020)

Bidirectional lysosome transport: a balancing act between ARL8 effectors
por: Kendrick, Agnieszka A., et al.
Publicado: (2022)

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

Publisher Correction: Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
por: Chen, Degao, et al.
Publicado: (2018)

COVID-19 mRNA vaccination and myocarditis or pericarditis
por: Husby, Anders, et al.
Publicado: (2022)

Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
por: Ju, Yi, et al.
Publicado: (2022)

Data from network meta-analyses can inform clinical practice guidelines and decision-making in diabetes management: perspectives of the taskforce of the guideline workshop
por: Ceriello, Antonio, et al.
Publicado: (2023)

AMPK/Ulk1-dependent autophagy as a key mTOR regulator in the context of cell pluripotency
por: Suvorova, Irina I., et al.
Publicado: (2019)

Effectiveness of mRNA booster doses against the omicron variant
por: Zedan, Hadeel T, et al.
Publicado: (2022)

Safety of mRNA COVID-19 vaccines during pregnancy
por: Ellington, Sascha, et al.
Publicado: (2022)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

The problem of selection bias in studies of pre-mRNA splicing
por: Dwyer, Zachary W., et al.
Publicado: (2023)

Global pediatric research investigator: Heba M. S. El Zefzaf
por: El Zefzaf, Heba Mohamed-Sobhy
Publicado: (2023)

Making policy decisions under plural uncertainty: responding to the COVID-19 pandemic
por: Ongaro, Malvina
Publicado: (2021)

The importance of representation in dermatology: Addressing disparities in eczema treatment and shared decision-making
por: Games, Margaux P., et al.
Publicado: (2023)

A Ca(2+) concentration of 1.5 mM, as present in IMDM but not in RPMI, is critical for maximal response of Th cells to PMA/ionomycin
por: Zimmermann, Jakob, et al.
Publicado: (2015)

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
por: Ligumsky, Hagai, et al.
Publicado: (2022)

Impact of methotrexate on first-dose COVID-19 mRNA vaccination
por: Connolly, Caoilfhionn M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eqenlmplaqns6475uae1b7hfli